Doug Rice

CFO

Equibles does not estimate personal net worth.

Get an email with a short summary when Mimedx Group, Inc. publishes a filing, an earnings call transcript or a press release.

Get MDXG alerts

About Doug Rice

Doug Rice is recorded as CFO at Mimedx Group, Inc. (MDXG) and CFO at Orthofix Medical Inc. (OFIX). Mimedx Group, Inc. reported in an 8-K filed July 5, 2023 that Doug Rice was appointed Chief Financial Officer, effective July 5, 2023. Doug Rice has spoken on 17 earnings calls across 2 companies, most recently for Mimedx Group, Inc. on October 28, 2026. Those appearances were for Mimedx Group, Inc. (MDXG) and Orthofix Medical Inc. (OFIX). Mimedx Group, Inc. is classified in the Biotechnology industry within the Healthcare sector. Orthofix Medical Inc. is classified in the Medical Devices industry within the Healthcare sector. Other leadership on record at Mimedx Group, Inc. includes K. Todd Newton (CEO and Board Member), Ricci S. Whitlow (COO), William L. Phelan (Chief Accounting Officer) and 7 others.

“On July 5, 2023, MiMedx Group, Inc. (the "Company") announced that Doug Rice has been appointed to serve as Chief Financial Officer of the Company, effective on July 5, 2023.”

Mimedx Group, Inc. Form 8-K, filed July 5, 2023 · Read the filing

Doug Rice on recent calls

“We are excited about our pending acquisition of Sonara MedTech and the opportunities it creates for our combined organization.”

CFO, MIMEDX Third Quarter 2026 Operating and Financial Results Conference Call · October 28, 2026

“I would like to start by echoing Joe's enthusiasm around today's announcement. We believe that the combination of Sonara's innovative portfolio and commercial momentum together with Mimedics' growing surgical footprint will create significant value.”

CFO, MIMEDX Second Quarter 2026 Operating and Financial Results Conference Call · July 29, 2026

“I'll let Joe comment on the customer piece. But you're right, Chase. Sequentially, we do expect modest recovery in wound, both on a dollar basis as well as a volume basis as we step through each quarter this year.”

CFO, Mimedx Group, Inc. Q1 FY2026 Earnings Call · April 29, 2026

“With regards to mix, we know some ASPs on some of our products did decrease throughout the year. And so, we've got pressure there, and we've also got some higher ASP products that offset some of that, but it's mostly a mix thing with regards to manufacturing sort of COGS and gross margin.”

CFO, Mimedx Group, Inc. Q1 FY2025 Earnings Call · April 30, 2025

“I'm pleased to review our results with you all today. As a reminder, many of the financial measures covered in today's call are on a non-GAAP basis.”

CFO, Mimedx Group, Inc. Q4 FY2024 Earnings Call · February 26, 2025